Features
In: Asia-Pacific Biotech News, Jg. 24 (2020-04-01), S. 22-39
Online
unknown
Zugriff:
COVID-19, caused by SARS-CoV-2, has taken 4, 613 lives and infected more than 125, 048 people globally as of 12 March 2020 a Phylogenetic anal showed that SAR-CoV-2 may have appeared since late Nov and spread through human-to-human transmission via contact or droplet Aerosol and oral-faecal routes are also gaining increasing attention and evidence Recently, virol study identified asymptomatic carriers with comparable viral load with other patients and asymptomatic transmission is widely suspected Chinese medicine is ancient yet innovative that it uses symptom-based diagnosis to stratify patients and formulate treatment, an approach which different disciplines of conventional medicine started to explore The focus of Chinese medicine is not on the virus, but on the overall clin presentation after the infection Chinese medicine treatment is personalized However, as each pestilence has a unique pattern, China′s national guideline (Guideline) on COVID-19 associated pneumonia could be considered as a reference At present, while we are waiting for more evidence on vaccines and pharmacol treatments from conventional medicine, we should not forget that Chinese medicine is an option that we could consider
Titel: |
Features
|
---|---|
Autor/in / Beteiligte Person: | Chan, KW ; Wong, Cwv |
Link: | |
Zeitschrift: | Asia-Pacific Biotech News, Jg. 24 (2020-04-01), S. 22-39 |
Veröffentlichung: | World Scientific Pub Co Pte Lt, 2020 |
Medientyp: | unknown |
ISSN: | 1793-6721 (print) ; 0219-0303 (print) |
DOI: | 10.1142/s0219030320000257 |
Schlagwort: |
|
Sonstiges: |
|